Search

Now showing items 1-1 of 1

rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: A comparison of two treatment regimens and placebo

Johnson B.J.; Bekker L.-G.; Rickman R.; Brown S.; Lesser M.; Ress S.; Willcox P.; Steyn L.; Kaplan G. (1997)

Setting: Low-dose recombinant human interleukin 2 (rhuIL-2) adjunctive immunotherapy in multidrug resistant tuberculosis (MDR-TB) patients. Objective: Evaluation of the effects of daily versus pulse-administered rhuIL-2 ...